Skip to content

Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation

Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02814578
Acronym
ACTIV-BVS
Enrollment
9
Registered
2016-06-27
Start date
2017-07-31
Completion date
2017-07-31
Last updated
2018-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

OCT, IVUS, BVS

Brief summary

The primary objective is to determine whether IVUS- (vs. OCT-) guided BVS implantation is non-inferior to achieve a large in-scaffold minimal lumen area (primary endpoint) measured by OCT at 1-year follow-up.

Interventions

comparative method for BVS

The method of goldstandard for decision stent choice

Sponsors

Abbott Medical Devices
CollaboratorINDUSTRY
Young-Hak Kim, MD, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 20 years or older * Patients who have at least one epicardial coronary artery lesion with an evidence of inducible ischemia * Willing and able to provide informed written consent * Eligible for PCI

Exclusion criteria

* Patients presenting with STEMI within 2 weeks * Bypass graft lesion * Lesion with left main disease * Expected length of scaffold \> 40 mm * Bifurcation lesion requiring side branch stenting * Small vessels \< 2.75 mm * Stented lesion * Suspected coronary spasm even after sufficient nitrate injected * Cases in which the IVUS or OCT imaging catheter failed to cross the lesion * Poor quality IVUS or OCT images * Contraindication to dual anti-platelet therapy * Chronic total occlusion * Angiographically large-sized vessel (\>3.5mm of reference lumen diameter) * Life expectancy shorter than 2 years * Pregnancy

Design outcomes

Primary

MeasureTime frame
OCT-measured in-scaffold minimal lumen area1 year

Secondary

MeasureTime frame
OCT-measured minimal scaffold area (MSA)1 year
OCT-measured mean scaffold expansion1 year

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026